Seek Labs Maps 25/25 Viral Families through BioSeeker, Advancing a New Model for Sequence-Directed Antiviral Discovery
The company’s comprehensive viral target atlas is designed to move development from reactive crisis response toward proactive, pre-identified genomic vulnerability mapping
Seek Labs Advances Development of Pan-Orthopoxvirus Therapeutic with BioSeeker™ and PTAP™
BioSeeker mapped more than 10,000 isolates and identified targetable regions that provide 100% strain coverage across the viral family.
Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network, Rapid Response Partnership Vehicle
Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network and Rapid Response Partnership Vehicle (RRPV)
Seek Labs Unveils BioSeeker™
Bioseeker™ is the AI Discovery Engine Powering Seek Labs’ Mission to Outpace Disease with Faster, Smarter Global Health Solutions
Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains
Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains
BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
Seek Labs Unveils BioSeeker™
Bioseeker™ is the AI Discovery Engine Powering Seek Labs’ Mission to Outpace Disease with Faster, Smarter Global Health Solutions
Seek Labs Announces Partnership with Cerbrec to Accelerate Diagnostic and Therapeutic Innovation with Graphbook Software
Seek Labs Announces Partnership with Cerbrec
Renowned African Swine Fever Researcher, Douglas Gladue, PhD, joins Seek Labs as Vice President of Veterinary Pharmaceutical Development
Renowned African Swine Fever Researcher, Douglas Gladue, PhD, joins Seek Labs as Vice President of Veterinary Pharmaceutical Development
Seek Labs Welcomes Alison O’Mahony, PhD as new Vice President of Pharmaceutical Research
SALT LAKE CITY, UT, February 22, 2024 (BusinessWire) – Seek Labs, a healthcare innovations company developing next-generation molecular diagnostic systems and novel gene therapies, announced today the appointment of Alison O’Mahony, PhD as Vice President of Pharmaceutical Development. With nearly 20 years of experience in R&D, phenotypic drug discovery, and assay and scientific operations, O’Mahony […]
Seek Labs Announces Completion of Office Expansion to Support Business Growth
Seek Labs Announces Completion of Office Expansion to Support Business Growth
Seek Labs Unveils SeekIt™
Seek Labs’ integrated molecular diagnostic platform brings true point-of-care testing to the patient.
